Charles River Laboratories International (CRL) Acquisitions (2016 - 2024)
Charles River Laboratories International has reported Acquisitions over the past 14 years, most recently at $5.5 million for Q2 2024.
- Quarterly results put Acquisitions at $5.5 million for Q2 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $5.5 million (down 96.35% YoY), and the annual figure for FY2024 was $5.5 million, down 97.19%.
- Acquisitions for Q2 2024 was $5.5 million at Charles River Laboratories International, down from $144.6 million in the prior quarter.
- Over the last five years, Acquisitions for CRL hit a ceiling of $906.3 million in Q2 2021 and a floor of -$518000.0 in Q4 2020.
- Median Acquisitions over the past 5 years was $94.2 million (2021), compared with a mean of $199.6 million.
- Peak annual rise in Acquisitions hit 38550.15% in 2020, while the deepest fall reached 1059.26% in 2020.
- Charles River Laboratories International's Acquisitions stood at -$518000.0 in 2020, then skyrocketed by 293.44% to $1.0 million in 2021, then soared by 28182.63% to $283.4 million in 2022, then plummeted by 48.97% to $144.6 million in 2023, then tumbled by 96.21% to $5.5 million in 2024.
- The last three reported values for Acquisitions were $5.5 million (Q2 2024), $144.6 million (Q4 2023), and $50.2 million (Q2 2023) per Business Quant data.